Form 8-K - Current report:
SEC Accession No. 0001213900-25-019437
Filing Date
2025-03-03
Accepted
2025-03-03 16:30:09
Documents
18
Period of Report
2025-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0232721-8k_oramed.htm   iXBRL 8-K 61318
2 PURCHASE AND SALE AGREEMENT, DATED FEBRUARY 28, 2025, BY AND AMONG SCILEX HOLDIN ea023272101ex10-1_oramed.htm EX-10.1 345404
3 SECURITY AGREEMENT, DATED FEBRUARY 28, 2025, BY AND AMONG SCILEX HOLDING COMPANY ea023272101ex10-2_oramed.htm EX-10.2 79749
4 SUBORDINATION AGREEMENT, DATED FEBRUARY 28, 2025, BY AND AMONG SCILEX HOLDING CO ea023272101ex10-3_oramed.htm EX-10.3 77910
5 AMENDMENT NO.1 TO PURCHASE AND SALE AGREEMENT, DATED FEBRUARY 28, 2025, BY AND A ea023272101ex10-4_oramed.htm EX-10.4 24433
6 LICENSE AGREEMENT (GLOPERBA), DATED FEBRUARY 28, 2025, BY AND BETWEEN SCILEX HOL ea023272101ex10-5_oramed.htm EX-10.5 265748
  Complete submission text file 0001213900-25-019437.txt   1206748

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ormp-20250228.xsd EX-101.SCH 3009
8 XBRL LABEL FILE ormp-20250228_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE ormp-20250228_pre.xml EX-101.PRE 22355
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0232721-8k_oramed_htm.xml XML 3807
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 25698463
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)